| Name | (5S,8R,9S,10S,13S,14S,17S)-10,13,17-trimethyl-1,4,5,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-ol |
|---|---|
| Synonyms |
(5α,17β)-17-Methylandrost-2-en-17-ol
Androst-2-en-17-ol, 17-methyl-, (5α,17β)- Madol Pheraplex Ba 2665 |
| Density | 1.0±0.1 g/cm3 |
|---|---|
| Boiling Point | 378.8±42.0 °C at 760 mmHg |
| Melting Point | 144-146ºC |
| Molecular Formula | C20H32O |
| Molecular Weight | 288.467 |
| Flash Point | 160.9±20.1 °C |
| Exact Mass | 288.245331 |
| PSA | 20.23000 |
| LogP | 6.43 |
| Vapour Pressure | 0.0±1.9 mmHg at 25°C |
| Index of Refraction | 1.532 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
|
~38%
3275-64-7 |
| Literature: UNIVERSITE LAVAL; POIRIER, Donald; ROY, Jenny; MALTAIS, Rene Patent: WO2010/60215 A1, 2010 ; Location in patent: Page/Page column 54; 93 ; |
|
~%
3275-64-7 |
| Literature: Journal of Medicinal Chemistry, , vol. 6, p. 156 - 161 |
|
~%
3275-64-7 |
| Literature: Journal of Medicinal Chemistry, , vol. 6, p. 156 - 161 |
| Precursor 4 | |
|---|---|
| DownStream 1 | |